AGP Wire

AGP

The transport media market is projected to rise from $3.5 billion in 2026 to $4.48 billion by 2030, driven by infectious-disease testing, molecular diagnostics, and sample-handling needs.

AGP

Health City Cayman Islands has completed the Caribbean’s first FARAPULSE pulsed field ablation procedure for atrial fibrillation, a milestone that could broaden access to advanced heart-rhythm treatment across the region.

AGP

The tumor blood testing market is projected to grow from $5.98 billion in 2025 to $11.13 billion by 2030 as cancer rates rise and demand increases for less invasive diagnostics.

AGP

The market for urethral stricture treatment devices is projected to grow from $1.47 billion in 2025 to $1.59 billion in 2026, driven by rising urological disease, aging populations and more minimally invasive care.

AGP

The upper-limb home therapy robot market is projected to grow from $1.7 billion in 2025 to $4.08 billion by 2030, driven by rising neurological disorders, home healthcare demand and remote rehabilitation tools.

AGP

The global trocars market is projected to grow from $1.06 billion in 2026 to $1.6 billion by 2030, driven by more minimally invasive surgery, outpatient procedures and rising demand for single-use devices.

AGP

The transcatheter mitral valve market is projected to grow from $1.61 billion in 2025 to $1.76 billion in 2026, with North America leading and Asia-Pacific set for the fastest growth.

AGP

The tissue heart valves market is projected to rise from $1.52 billion in 2025 to $1.72 billion by 2030, driven by aging populations, cardiovascular disease growth and wider use of transcatheter procedures.

AGP

The home health monitoring devices market is projected to rise from $1.42 billion in 2025 to $1.49 billion in 2026, then reach $1.83 billion by 2030, according to The Business Research Company.

AGP

The transcranial magnetic stimulator market is projected to grow from $1.39 billion in 2025 to $1.52 billion in 2026, with the forecast pointing to $2.21 billion by 2030. The report points to rising neurological disorders, broader use of non-drug…

AGP

The transplant diagnostics market is projected to grow from $2.07 billion in 2025 to $2.96 billion by 2030, driven by more organ transplants, better testing technology and wider use of AI and next-generation sequencing.

AGP

The global tubeless insulin pump market was valued at $2.2 billion in 2025 and is projected to reach $5.28 billion by 2030, driven by rising diabetes cases, wearable tech adoption and wider use of remote monitoring.

AGP

The tuberculosis diagnostics market is projected to grow from $2.52 billion in 2026 to $3.37 billion by 2030, driven by rising TB cases, demand for faster testing and broader use of molecular diagnostics.

AGP

The total ankle replacement market is projected to grow from $0.99 billion in 2025 to $1.43 billion by 2030, driven by rising arthritis cases, orthopedic trauma and new surgical techniques.

AGP

The tumor ablation market is forecast to grow from $1.62 billion in 2025 to $2.69 billion by 2030, driven by demand for minimally invasive cancer treatment and precision oncology.

AGP

The transcatheter valve repair system market is projected to grow from $5.45 billion in 2025 to $8.42 billion by 2030, driven by rising heart disease, aging populations and broader use of minimally invasive cardiac procedures.

AGP

The urinary catheters market is expected to grow from $5.98 billion in 2025 to $8.31 billion by 2030, driven by rising chronic disease rates, an aging population and demand for infection-resistant devices.

AGP

The ultrasonic surgical cutters market was valued at $1.49 billion in 2025 and is forecast to hit $1.91 billion by 2030, driven by more minimally invasive procedures, higher surgical volumes and better ultrasonic technology.

AGP

The market for ultrasound and electrosurgical energy dissectors is forecast to grow from $6.86 billion in 2025 to $7.35 billion in 2026, with demand rising from minimally invasive surgery and higher healthcare spending.

AGP

The tumor ablation therapy devices market is forecast to grow from $0.95 billion in 2026 to $1.61 billion by 2030, driven by rising cancer cases, outpatient care demand and more image-guided procedures.